Evidence map›Paper›PMID 33408225›Full record

ArticlemSphere2021

Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34

Meaghan H Hancock, Lindsey B Crawford, Wilma Perez, Hillary M Struthers, Jennifer Mitchell, Patrizia Caposio

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Viral miRNA regulation of host gene expression.Seminars in cell & developmental biology · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Hematopoietic stem cells and betaherpesvirus latency.Frontiers in cellular and infection microbiology · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Meaghan H HancockVaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-2945-0147
Lindsey B CrawfordVaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-1248-253X
Wilma PerezVaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.
Hillary M StruthersVaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.
Jennifer MitchellVaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.
Patrizia CaposioVaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA caposiop@ohsu.edu.ORCID 0000-0001-7579-849X
Oregon Health & Science University · US

Funding

The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI JAY A NELSON · 2017 to 2026
$24.6M
Molecular Aspects of Cytomegalovirus LatencyR37AI021640 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HANCOCK, MEAGHAN H · 2018 to 2024
$4.0M
NIAID NIH HHS P01 AI127335NIAID NIH HHS R37 AI021640
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) infection of myeloid lineage cells, such as CD34

Indexed as

ApoptosisAntigens, CD34Cells, CulturedCytomegalovirusFibroblastsHEK293 CellsHematopoietic Stem CellsHumansMicroRNAsViral Matrix ProteinsAntigens, CD34MicroRNAsmicroRNA-UL112, human cytomegalovirusViral Matrix ProteinsapoptosisFOXO3ahematopoietic progenitor cellshuman cytomegalovirus

Identifiers

PMID33408225
PMCPMC7845589
OpenAlexW3119887453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.